Lamotrigine as add-on treatment to lithium and divalproex: Lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder

Bipolar Disorders

Volumn 14, Issue 7, 2012, Pages 780-789

  Kemp, David E ^a   Gao, Keming ^a   Fein, Elizabeth B ^a   Chan, Philip K ^a   Conroy, Carla ^a   Obral, Sarah ^a   Ganocy, Stephen J ^a   Calabrese, Joseph R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bipolar depression; Combination treatment; Divalproex; Failed clinical trial; Lamotrigine; Lithium; Rapid cycling

Indexed keywords

LAMOTRIGINE; LITHIUM; LORAZEPAM; PLACEBO; VALPROATE SEMISODIUM; ZOLPIDEM;

ADD ON THERAPY; ADULT; AGED; ANALYSIS OF COVARIANCE; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG STABILITY; DRUG TOLERABILITY; DSM-IV; FEMALE; HUMAN; HYPOMANIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL PATIENT; MIXED MANIA AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; RASH; REMISSION; SIDE EFFECT; SUICIDAL BEHAVIOR; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CHLORIDE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; TRIAZINES; VALPROIC ACID; YOUNG ADULT;

EID: 84868131486     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12013     Document Type: Article

References (42)

1. Kupka RW, Luckenbaugh DA, Post RM et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64: 1483-1494.
2. Azorin JM, Kaladjian A, Adida M et al. Factors associated with rapid cycling in bipolar I manic patients: findings from a French National Study. CNS Spectr 2008; 13: 780-787.
3. Perugi G, Micheli C, Akiskal HS et al. Polarity of the first episode, clinical characteristics, and course of manic-depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry 2000; 41: 13-18.
4. Calabrese JR, Delucci GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147: 431-434.
5. Calabrese JR, Markovitz PJ, Kimmel SE et al. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992; 12 (Suppl. 1): 53S-56S.
6. Calabrese JR, Shelton MD, Rapport DJ et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162: 2152-2161.
7. Kemp DE, Gao K, Ganocy SJ et al. A 6-month, double-blind, maintenance trail of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 2009; 70: 113-121.
8. Calabrese JR, Shelton MD, Bowden CL et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001; 62: 34-41.
9. Geddes JR, Burgess S, Hawton K et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-222.
10. Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-395.
11. Schneck CD, Miklowitz DJ, Miyahara S et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165: 370-377.
12. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
13. Calabrese JR, Bowden CL, Sachs G et al. Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013-1024.
14. Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry 2000; 61: 841-850.
15. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
16. van der Loos ML, Mulder PG, Hartong EG et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 2009; 70: 223-231.
17. Levine J, Chengappa KNR, Brar JS et al. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord 2000; 2: 120-130.
18. Goldberg JF, Brooks JO 3rd, Kurita K et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry 2009; 70: 155-162.
19. Post RM, Roy-Byrne PP, Uhde TW. Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988; 145: 844-848.
20. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 384-389.
21. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20): 22-33.
22. First MB, Spitzer RL, Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorder-Patient Edition (SCID-I/P, Version 2.0, 4/97 Revision). New York: New York State Psychiatric Institute, 1997.
23. Young RC, Biggs JT, Ziegler VE et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
24. Spearing MK, Post RM, Leverich GS et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159-171.
25. Endicott J, Spitzer RL, Fleiss JL et al. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
26. Wang Z, Gao K, Kemp DE et al. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Psychopharmacol Bull 2010; 43: 5-21.
27. Calabrese JR, Huffman RF, White RL et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008; 10: 323-333.
28. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009; 194: 4-9.
29. Coryell W, Solomon D, Turvey C et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60: 914-920.
30. Leon AC, Davis LL. Enhancing clinical trial design of interventions for posttraumatic stress disorder. J Trauma Stress 2009; 22: 603-611.
31. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722.
32. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry 2003; 64: 1091-1093.
33. Storosum JG, Fouwels A, Gispen-de Wied CC, Wohlfarth T, van Zwieten BJ, van den Brink W. How real are patients in placebo-controlled studies of acute manic episode? Eur Neuropsychopharmacol 2004; 14: 319-323.
34. Kemp DE, Muzina DJ, McIntyre RS, Calabrese JR. Bipolar depression: trial-based insights to guide patient care. Dialogues Clin Neurosci 2008; 10: 181-192.
35. Langosch JM, Drieling T, Biedermann NC et al. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol 2008; 28: 555-560.
36. Goldberg JF, Kelley ME, Rosenquist KJ, Hsu DJ, Filkowski MM, Nassir Ghaemi S. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord 2008; 105: 305-310.
37. Thase ME, Macfadden W, Weisler RH et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006; 26: 600-609.
38. Calabrese JR, Keck PE Jr, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351-1360.
39. Young AH, McElroy SL, Bauer M et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010; 71: 150-162.
40. McElroy SL, Weisler RH, Chang W et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010; 71: 163-174.
41. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088.
42. van der Loos ML, Mulder P, Hartong EG et al. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo andparoxetine. Acta Psychiatr Scand 2010; 122: 246-254.